{'fraction_non_alphanumeric': 0.0196078431372549, 'fraction_numerical': 0.008714596949891068, 'mean_word_length': 5.216216216216216, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Thrombolytic therapy in patients with acute ischemic stroke.

Stroke is the leading cause of disability in the United States and the third leading cause of death. Of long-term stroke survivors, 30% are dependent on others for help with activities of daily living and 15% require institutional care. Traditional care for patients with stroke has focused on treating complications and preventing recurrent strokes; the stroke itself was considered irreversible.